Home > Analytics > TATVA CHINTAN PHARMA CHEM

TATVA CHINTAN PHARMA CHEM
Intrinsic Value | Fundamental Analysis

BOM : 543321     NSE : TATVA    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Nov 25,2022
Price(EOD): ₹ 2,289.85
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Chemicals
MCap: ₹ 5,083.47 Cr
Value of ₹ 1 Lac invested in TATVA CHINTAN PHARMA CHEM
on Jul 29,2021 (price: ₹ 2,310.25)

₹ 1 L

₹ 0.99 L

1W : -2.1% 1M : -5.8% 1Y : -12.3%
COMMUNITY POLL
for TATVA CHINTAN PHARMA CHEM
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
TATVA CHINTAN PHARMA CHEM -2.1% -5.8% -12.3%
PIDILITE INDUSTRIES -0% 1.7% 15.6%
AARTI INDUSTRIES -0.7% -3.2% -29.4%
DEEPAK NITRITE 0.1% -6.4% -2.3%
ATUL 0.9% -0.2% -7.5%
ALKYL AMINES CHEMICALS 3% -3.5% -13.2%
TATA CHEMICALS -0.4% -12.5% 12.1%
NAVIN FLUORINE INTERNATIONAL 1% -2.1% 23.2%
GODREJ INDUSTRIES 5.5% -0.3% -32%

FUNDAMENTAL ANALYSIS OF TATVA CHINTAN PHARMA CHEM

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF TATVA CHINTAN PHARMA CHEM

 
Valuation Score
[As on : Nov 25,2022 ]

Ratio Consolidated
P/E
P/B
P/S
88.69
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 57.23 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

10.73
P/B Calculated based on Book Value of Rs 473.09 Cr
[Latest Year - Mar2022 - Consolidated Results ]

13.3
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 381.69 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF TATVA CHINTAN PHARMA CHEM

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
32197%
32334%
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF TATVA CHINTAN PHARMA CHEM



TATVA CHINTAN PHARMA CHEM vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF TATVA CHINTAN PHARMA CHEM

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.26
0.56
0.79
0.54
0.25
0.54
0.77
0.52
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF TATVA CHINTAN PHARMA CHEM

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF TATVA CHINTAN PHARMA CHEM

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
1.91%
-26.54%
-33.86%
-27.41%
-27.12%
-68.47%
-74.42%
-78.06%
QtrlyTrend
-6
Latest Qtr: Sep2022
Quarterly Result Analysis →


TATVA CHINTAN PHARMA CHEM related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 1.7% 1.9% 3%
S&P BSE SMALL CAP 1.6% 1.2% 4.5%
S&P BSE ALLCAP 1.1% 3.3% 5.4%
S&P BSE BASIC MATERIALS 0.6% 5.5% 0.8%
No NSE index found

You may also like the below Video Courses


FAQ about TATVA CHINTAN PHARMA CHEM


Is TATVA CHINTAN PHARMA CHEM good for long term investment?

As on Nov 25,2022, the Fundamentals of TATVA CHINTAN PHARMA CHEM look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of TATVA CHINTAN PHARMA CHEM . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TATVA CHINTAN PHARMA CHEM UnderValued or OverValued?

As on Nov 25,2022, TATVA CHINTAN PHARMA CHEM is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of TATVA CHINTAN PHARMA CHEM ?

As on Nov 25,2022, the Intrinsic Value of TATVA CHINTAN PHARMA CHEM is Rs. 7.07 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 7.09
Fair Value [Median EV / Sales Model] : Rs. 7.06
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of TATVA CHINTAN PHARMA CHEM : Rs. 7.07

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is TATVA CHINTAN PHARMA CHEM trading at a Premium or Discount?

As on Nov 25,2022, TATVA CHINTAN PHARMA CHEM is trading at a Premium of 32268% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].